Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1W41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,598
Award facts
- Contract value 100% obligated
- $58,598.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 21, 2026, by the Defense Logistics Agency (DLA) for the supply of Dupixent 300 mg/2 mL pen injectors, valued at $58,598.33 with a firm fixed price structure. The delivery order is scheduled for completion by January 22, 2026, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, leveraging the company's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026.
Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Dupixent, a prescription medication used in the treatment of atopic dermatitis, eczema, and other allergic conditions, represents part of the company's ongoing role in supporting Defense Health Agency medical supply requirements. The contract demonstrates the company's capability to fulfill federal procurement needs through its established relationship with the DLA Medical Supply Chain and its competitive performance in the pharmaceutical distribution sector.
Quick answers
Who was awarded contract SPE2DR26F1W41?
SPE2DR26F1W41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1W41 worth?
The government has obligated $58,598 on SPE2DR26F1W41.
Is contract SPE2DR26F1W41 an order under another contract?
Yes. SPE2DR26F1W41 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W41 competed?
The extent of competition for SPE2DR26F1W41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award